Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study uncovers genes contributing to Thoroughbred fractures
Approximately 60 horses euthanised on racecourses due to fractures each year.
Researchers identified 112 genes which regulate the bone matrix.

New research from the Royal Veterinary College (RVC) has identified 112 genes which might be contributing to bone fracture risk among Thoroughbred horses.

Although a large number of these genes have never been studied, researchers were able to demonstrate how these genes regulate the bone matrix.

Due to the force that their bones can experience, Thoroughbred horses are particularly susceptible to bone fractures. The complexity of the condition means that fractures are also a leading cause of euthanasia, with approximately 60 horses euthanised at UK racecourses each year.

This genetic study is the second of a series from RVC, as it explores the genetic mechanisms behind fracture risk.

The project saw a group of researchers utilise a polygenic risk score for fracture risk, using it to establish a new model examining how stem cells make bone-forming cells for horses at high and low risk of bone fracture.

Using this model, a team of researchers measured every gene that was expressed by the cells. This would then identify the genes with different expression levels in bone cells of horses with higher or lower risk of fractures.

Researchers were able to identify 112 genes involved in fracture risk and demonstrate how these genes regulate the bone matrix.

Many of these genes have not been studied before and so more research is needed to understand their function in bone cells. Additional research is also being conducted to validate the new risk-scoring system in another group of horses.

Debbie Guest, senior research fellow at RVC, said: “In this study, we have identified many new genes which have altered expression in bone cells from high-risk horses.

“For some of these genes, we know that they play a role in regulating the bone matrix. We can now begin to develop a deeper understanding of how bone tissue is altered in high-risk horses and new interventions to reduce their risk.”

The first study in the research series discovered that collagen type III, required for normal bone formation, was expressed at lower levels in the bone cells from horses at high genetic risk of fracture. This is as a result of a change in their DNA sequences affecting how much collagen III is produced.

The latest study has been published in the journal Anim Genet. The previous study is published in the journal Animals.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.